SACHI BIOWORKS, INC.

Sachi Bioworks, Inc. specializes in advanced biomedical research and development focused on mitigating physiological stressors in spaceflight environments, particularly immune dysregulation and drug discovery under microgravity conditions. The company leverages proprietary nanoligomer technology to develop rapid, low-cost therapeutic platforms tailored for space missions, demonstrating deep expertise in life sciences R&D, immunomodulatory pharmacology, and space physiology. Their work bridges molecular biology, nanotechnology, and aerospace medicine, with a unique focus on translating terrestrial biomedical innovations into viable countermeasures for long-duration spaceflight. Key differentiators include their ability to design scalable, space-optimized drug delivery systems and their proven success in advancing SBIR-phase innovations from proof-of-concept to operational readiness. The contractor maintains a consistent, high-trust relationship with NASA, delivering mission-critical research under the Small Business Innovation Research program. All recent awards stem from NASA’s SBIR initiative, indicating a specialized focus on solving astronaut health challenges through innovative biotechnology. Their work supports NASA’s Human Research Program, with a clear emphasis on translational science that directly informs crew health protocols for lunar and Mars missions. Sachi Bioworks operates primarily within NAICS 541715, which encompasses applied research in life sciences excluding nanotechnology and biotechnology—though their use of nanoligomers suggests a nuanced, mission-driven application of nanoscale tools within this classification. Their market positioning is highly specialized: they are a niche provider of space-adapted biomedical solutions, serving the growing demand for in-flight medical countermeasures in the commercial and government space sectors. As a small business structured as a 2L entity based in Erie, Colorado, Sachi Bioworks operates without federal certifications but maintains a focused, high-impact presence in the aerospace life sciences market. Their geographic location supports collaboration with regional research institutions and aerospace partners, reinforcing their role as a specialized innovator in space health R&D.